LCM
RMD icon

Logan Capital Management’s ResMed RMD Stock Holding History

Logan Capital Management’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-8
Closed -$1.38K – 491
2023
Q4 		$1.38K Sell
8
-7
-47% -$1.08K ﹤0.01% 467
2023
Q3 		$2.22K Hold
15
– – ﹤0.01% 448
2023
Q2 		$3.28K Hold
15
– – ﹤0.01% 435
2023
Q1 		$3.28K Hold
15
– – ﹤0.01% 447
2022
Q4 		$3.12K Hold
15
– – ﹤0.01% 477
2022
Q3 		$3K Hold
15
– – ﹤0.01% 466
2022
Q2 		$3K Hold
15
– – ﹤0.01% 493
2022
Q1 		$4K Buy
+15
New +$3.63K ﹤0.01% 488
2015
Q2 		– Sell
-3,000
Closed -$215K – 299
2015
Q1 		$215K Buy
+3,000
New +$195K 0.02% 266

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Logan Capital Management's RMD Position: Q1 2024 in Review

Logan Capital Management sold out of ResMed (RMD) in Q1 2024, closing a stake of 8 shares — an estimated $1.38K sold.

Logan Capital Management first reported a position in RMD in Q1 2015 and held it in 9 quarters. The position peaked at $215K in Q1 2015. 718 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Logan Capital Management reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
  • Logan Capital Management sold 8 ResMed shares in Q1 2024, an estimated $1.38K.
  • Logan Capital Management first reported a position in ResMed in Q1 2015 and held it in 9 quarters.
  • Logan Capital Management's ResMed position peaked at $215K in Q1 2015.
  • 718 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Logan Capital Management's 13F filing for Q1 2024, filed 13 May 2024.